These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20086170)

  • 21. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution.
    Basha R; Connelly SF; Sankpal UT; Nagaraju GP; Patel H; Vishwanatha JK; Shelake S; Tabor-Simecka L; Shoji M; Simecka JW; El-Rayes B
    J Nutr Biochem; 2016 May; 31():77-87. PubMed ID: 27133426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites.
    Lee TJ; Jung EM; Lee JT; Kim S; Park JW; Choi KS; Kwon TK
    Mol Cancer Ther; 2006 Nov; 5(11):2737-46. PubMed ID: 17121920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
    Choi ES; Shim JH; Jung JY; Kim HJ; Choi KH; Shin JA; Nam JS; Cho NP; Cho SD
    Cancer Sci; 2011 Apr; 102(4):742-8. PubMed ID: 21241418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.
    Rao M; Atay SM; Shukla V; Hong Y; Upham T; Ripley RT; Hong JA; Zhang M; Reardon E; Fetsch P; Miettinen M; Li X; Peer CJ; Sissung T; Figg WD; De Rienzo A; Bueno R; Schrump DS
    Clin Cancer Res; 2016 Mar; 22(5):1197-210. PubMed ID: 26459178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer.
    Logotheti S; Michalopoulos I; Sideridou M; Daskalos A; Kossida S; Spandidos DA; Field JK; Vojtesek B; Liloglou T; Gorgoulis V; Zoumpourlis V
    FEBS J; 2010 Jul; 277(14):3014-27. PubMed ID: 20528922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts.
    Zhao Y; Zhang W; Guo Z; Ma F; Wu Y; Bai Y; Gong W; Chen Y; Cheng T; Zhi F; Zhang Y; Wang J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1782-92. PubMed ID: 23877322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy.
    Tonra JR; Deevi DS; Corcoran E; Li H; Wang S; Carrick FE; Hicklin DJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2197-207. PubMed ID: 16609035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1.
    Liu R; Zhi X; Zhou Z; Zhang H; Yang R; Zou T; Chen C
    Sci Rep; 2018 Jan; 8(1):1138. PubMed ID: 29348684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
    Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
    Pathi S; Li X; Safe S
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer.
    Choi ES; Nam JS; Jung JY; Cho NP; Cho SD
    Sci Rep; 2014 Nov; 4():7162. PubMed ID: 25418289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.
    Jin K; Lan H; Xie B; He K; Xu Z; Li G; Han N; Teng L; Cao F
    Cancer Biol Ther; 2012 Jul; 13(9):737-44. PubMed ID: 22617773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway.
    Liu W; Zhang J; Yao X; Jiang C; Ni P; Cheng L; Liu J; Ni S; Chen Q; Li Q; Zhou K; Wang G; Zhou F
    Cancer Sci; 2018 Oct; 109(10):3294-3304. PubMed ID: 30151975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
    Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
    Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
    Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
    Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.
    Sankpal UT; Ingersoll SB; Ahmad S; Holloway RW; Bhat VB; Simecka JW; Daniel L; Kariali E; Vishwanatha JK; Basha R
    Tumour Biol; 2016 Oct; 37(10):14259-14269. PubMed ID: 27581819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.
    Sleiman SF; Langley BC; Basso M; Berlin J; Xia L; Payappilly JB; Kharel MK; Guo H; Marsh JL; Thompson LM; Mahishi L; Ahuja P; MacLellan WR; Geschwind DH; Coppola G; Rohr J; Ratan RR
    J Neurosci; 2011 May; 31(18):6858-70. PubMed ID: 21543616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mithramycin inhibits epithelial-to-mesenchymal transition and invasion by downregulating SP1 and SNAI1 in salivary adenoid cystic carcinoma.
    Li J; Gao H; Meng L; Yin L
    Tumour Biol; 2017 Jun; 39(6):1010428317708697. PubMed ID: 28631560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells.
    Lu S; Archer MC
    Int J Cancer; 2010 Jan; 126(2):416-25. PubMed ID: 19621387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells.
    Dauer P; Sharma NS; Gupta VK; Nomura A; Dudeja V; Saluja A; Banerjee S
    Mol Oncol; 2018 Sep; 12(9):1498-1512. PubMed ID: 29738634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.